ZCCHC11 Antikörper (AA 250-300)
-
- Target Alle ZCCHC11 Antikörper anzeigen
- ZCCHC11 (Zinc Finger, CCHC Domain Containing 11 (ZCCHC11))
-
Bindungsspezifität
- AA 250-300
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ZCCHC11 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit anti-ZCCHC11 Antibody, Affinity Purified
- Homologie
- Mouse
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 250 and 300
- Isotyp
- IgG
- Top Product
- Discover our top product ZCCHC11 Primärantikörper
-
-
- Applikationshinweise
-
IP: Not recommended. In an initial assessment, ZCCHC11 did not appear to be efficiently immunoprecipitated when using this antibody.
WB: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 200 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- ZCCHC11 (Zinc Finger, CCHC Domain Containing 11 (ZCCHC11))
- Andere Bezeichnung
- ZCCHC11 (ZCCHC11 Produkte)
- Synonyme
- PAPD3 antikoerper, TUT4 antikoerper, ZCCHC11 antikoerper, DKFZp459G145 antikoerper, 6030404K05Rik antikoerper, 9230115F04Rik antikoerper, PPAPD3 antikoerper, mKIAA0191 antikoerper, wu:fc06h08 antikoerper, wu:fy37g11 antikoerper, papd3 antikoerper, zinc finger CCHC-type containing 11 antikoerper, zinc finger, CCHC domain containing 11 antikoerper, zinc finger CCHC domain containing 11 antikoerper, ZCCHC11 antikoerper, Zcchc11 antikoerper, zcchc11 antikoerper
- Hintergrund
- Background: ZCCHC11 (zinc-finger CCHC domain-containing protein 11) functions as a uridylyltransferase that acts as a suppressor of microRNA (miRNA) biogenesis by specifically mediating the terminal uridylation of some miRNAs.
- Gen-ID
- 23318
- NCBI Accession
- NP_056084
- UniProt
- Q5TAX3
- Pathways
- Stem Cell Maintenance
-